Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

BDB001-102 Open Label Dose Escalation Combination w Atezolizumab

BDB001-102 Open Label Dose Escalation Combination w Atezolizumab
Condition:   Tumor, Solid
Interventions:   Drug: BDB001;   Drug: Atezolizumab
Sponsors:   Birdie Biopharmaceuticals HK Limited;   Seven and Eight Biopharmaceuticals Inc
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 13, 2019 / by / in
Comments